Medical/Pharmaceuticals
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...
2022-10-25 20:00
3603
FDA Accepts NMP's Clinical Trial Application for Development of NMK89 as Imaging Agent for Cancer Diagnosis
- Clinical Study Set to Begin, Focusing on Diagnostic Use of Theranostics - TOKYO, Oct. 25, 2022 /PRNewswire/ -- Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company inJapan, is pleased to announce that the U.S. Food and Drug Administration (FDA) has recently accepted NMP's ...
2022-10-25 16:00
2338
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report
Report analyzes benefits, financing, R&D activity and more to reveal emerging standouts in medical science United States and Mainland China at the forefront of RNA technology advancement LONDON, Oct. 25, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted inform...
2022-10-25 15:19
2370
BioCell Technology Expands Global Presence and Trust with Prestigious Halal Certification
BioCell Collagen®, the company's flagship ingredient, is now halal-certified by the Islamic Information Documentation and Certification GmbH (IIDC), an accreditation accepted in nearly all Islamic countries IRVINE, Calif., Oct. 25, 2022 /PRNewswire/ -- BioCell Collagen®, a clinically-studied die...
2022-10-25 12:00
3644
MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program
MiRXES Translator Program will accelerate revenue growth of start-ups and
importantly, adoption of preventive healthcare solutions globally
SINGAPORE, Oct. 25, 2022 /PRNewswire/ -- MiRXES
2022-10-25 11:50
4760
MedAlliance SELUTION SLR Receives Coronary FDA IDE Approval
GENEVA, Oct. 25, 2022 /PRNewswire/ -- Following our communication last week
"MedAlliance to be acquired by Cordis",MedAlliance is pleased to make the
following announcement:
2022-10-25 08:00
4147
T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness
* Preclinical data showing how ERA™, eTurna™ technologies turbocharge T-cell therapies presented at New Frontiers of RNA Nanotherapeutics meeting today * ERA™ boosts CAR T-cell efficacy by overcoming T-cell exhaustion that inhibits cancer cures * eTurna™ delivery platform delivers more healt...
2022-10-24 23:30
3938
deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). REYKJAVIK, Iceland, Oct. 24, 2022 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, publish t...
2022-10-24 23:00
4181
ReviR Therapeutics Expands Research Team by Appointing Dr. Sridhar Narayan as Head of Medicinal Chemistry
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, recently announced the appointment of Dr.Sridhar Narayan as Vice President responsible for the global Medicinal Chemistry team. "I am d...
2022-10-24 22:00
3183
Transcenta to Participate in Four Upcoming Conferences
SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management ...
2022-10-24 21:00
4551
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 24, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...
2022-10-24 21:00
3579
Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML
SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutatio...
2022-10-24 20:14
4333
India's most advanced and largest IVF clinic group, Indira IVF, will offer all patients Artificial Intelligence technology to improve pregnancy outcomes
SAN FRANCISCO, Oct. 24, 2022 /PRNewswire/ -- The largest and most advanced IVF clinic group inIndia, Indira IVF, will be rolling out the latest in Artificial Intelligence technology across their 100+ clinics inIndia in November 2022. This AI technology, called Life Whisperer, has been tested in a...
2022-10-24 20:05
3218
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19
HONG KONG, Oct. 24, 2022 /PRNewswire/ -- A randomised, double-blind controlled study conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) showed that SIM01, a CUHK-developed microbiome formula, successfully reduced adverse events in high-risk individuals such...
2022-10-24 17:59
4674
Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting
SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that Transcenta is i...
2022-10-24 16:08
3723
United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT
* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...
2022-10-24 16:00
2656
United Imaging Healthcare Attends European Association of Nuclear Medicine Congress With uEXPLORER®, The World's First Total-Body PET/CT
* To provide tailored, precise solutions and bring the value of molecular imaging to patient care BARCELONA, Spain, Oct. 24, 2022 /PRNewswire/ -- United Imaging Healthcare (UIH), a global innovator in advanced medical imaging, debuts at the European Association of Nuclear Medicine (EANM) Congre...
2022-10-24 15:13
2882
Prenatal Genetic Testing Market to Improve Accuracy Through Technological Advances
Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, says Frost & Sullivan SAN ANTONIO, Oct. 24, 2022 /PRNewswire/ -- Rising patient awareness drives technological advances and expands marketing for prenatal genetic tests globally, acc...
2022-10-24 15:12
1866
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities
* WuXi Biologics adds further capacity and capability for drug product fill & finish, providing global customers with end-to-end integrated solutions for diversified modalities, including mRNA-LNP HANGZHOU, China, Oct. 23, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading gl...
2022-10-24 08:30
3058
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
GAITHERSBURG, Md., Oct. 22, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received eme...
2022-10-22 03:25
9552
Week's Top Stories
Most Reposted
TD Brings its Global Asset Management Businesses Under One Name
[Picked up by 1168 media titles]
2026-11-02 20:00OceanaGold Reports Third Quarter 2026 Results
[Picked up by 1129 media titles]
2026-11-05 06:52Overstory Launches Integrated AI Platform to Deliver First Living Model of Grid Risk
[Picked up by 1082 media titles]
2026-11-03 22:00Fintech OPay Raises $304 Million Ahead of NYSE Debut: NYSE Content Update
[Picked up by 1079 media titles]
2026-10-30 22:34
H.E. Ahmed Al-Khateeb, Saudi Minister of Tourism, Inaugurates Saudi Land at WTM London 2026, Reinforcing Saudi's Commitment to Global Travel Trade
[Picked up by 1067 media titles]
2026-11-04 07:31
Most Read
1B views since June: Coda and TikTok Gaming turn content into commerce
2026-11-02 09:35
61397
Airbrush Upgrades AI Image Enhancer With 16K Output and Batch Processing for Up to 50 Images
2026-11-03 02:00
56941
iQIYI Launches China's First AI Film Studio in Shanghai, with Inaugural Title "Cop in Trouble" in Production
2026-11-02 09:52
54475
Korean Derma Skincare Brand MDP+ Launches at Nordstrom
2026-11-03 00:30
23939
